ArticleESC heart failure2026
Anxiety and/or depression in heart failure across the ejection fraction spectrum: the SwedeHF registry.
Article in ESC heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionLimited data exist on characteristics and clinical outcomes associated with anxiety and/or depression in heart failure (HF) across the different ejection fraction (EF) categories, particularly when considering aspects of health-related quality of life (HRQoL). To assess characteristics and clinical outcomes associated with anxiety and/or depression in patients with preserved, mildly reduced, and reduced EF (HFpEF, HFmrEF, and HFrEF).
methodsPatients were included from the Swedish Heart Failure Registry in 2008-23. Anxiety and/or depression levels (none, moderate, or severe) were self-reported using the EuroQoL five-dimensional three-level questionnaire (EQ-5D-3L). Multivariable multinomial regression was used to analyse baseline characteristics independently associated with self-reported anxiety/depression, with and without HRQoL adjustment. Time-to-first HF hospitalization (HFH), all-cause hospitalization, all-cause and cardiovascular (CV) death were assessed using Cox proportional hazards models.
resultsAmong 57 251 patients, 58% reported no, 38% moderate, and 4% severe symptoms of anxiety/depression, with similar distributions across EF categories. Self-reported anxiety/depression were associated with reduced HRQoL components. Without HRQoL adjustment, significant associations included higher NYHA class, liver disease, smoking, female sex, younger age, and inpatient status. Self-reported anxiety/depression levels were associated with higher risks of all outcomes at 12 months. After HRQoL adjustments, self-reported anxiety/depression remained associated with HFH and all-cause hospitalization but not death.
conclusionSelf-reported anxiety/depression were common across all HF categories, significantly associated with HRQoL, and associated with increased risk of HFH, all-cause hospitalization and death, but their impact on mortality diminished after adjustment for HRQoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.